Protara Therapeutics, Inc. Accumulated Other Comprehensive Income
Protara Therapeutics, Inc. (TARA) had Accumulated Other Comprehensive Income of -$363.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$363.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$364.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $90.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $143.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$363.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$364.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $90.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $143.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $77.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $89.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.00K 10-K · filed 2026-03-10 |
| 2024-09-30 | $29.00K 10-Q · filed 2024-11-12 |
| 2024-03-31 | -$1.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$31.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | -$165.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | -$336.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$469.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | -$688.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$1.13M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$1.12M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$942.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$211.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | -$39.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$101.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$164.00K 10-Q · filed 2021-05-06 |
| 2019-12-31 | $3.00K 10-K · filed 2020-03-20 |
| 2019-09-30 | $2.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $4.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.00K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $5.00K 10-K · filed 2020-03-20 |
| 2018-09-30 | $4.00K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | -$4.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$14.00K 10-K · filed 2019-03-13 |
| 2017-09-30 | -$7.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$7.00K 10-Q · filed 2017-08-07 |
| 2016-09-30 | $8.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $10.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $12.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$11.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $6.00K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $3.00K 10-Q · filed 2015-08-13 |
| 2014-12-31 | -$6.00K 10-K · filed 2016-03-14 |
| 2014-09-30 | -$11.00K 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |